# CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study

> **NCT04138316** · — · COMPLETED · sponsor: **Hospital Clínico Universitario de Valladolid** · enrollment: 85 (actual)

## Conditions studied

- Migraine
- Head Pain

## Interventions

- **DRUG:** Candesartan

## Key facts

- **NCT ID:** NCT04138316
- **Lead sponsor:** Hospital Clínico Universitario de Valladolid
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-02
- **Primary completion:** 2022-12-16
- **Final completion:** 2022-12-16
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2022-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04138316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04138316, "CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04138316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*